191 related articles for article (PubMed ID: 21691207)
1. Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.
Campitelli MA; Chiarelli AM; Mirea L; Stewart L; Glendon G; Ritvo P; Andrulis IL; Knight JA
Eur J Cancer Prev; 2011 Nov; 20(6):492-500. PubMed ID: 21691207
[TBL] [Abstract][Full Text] [Related]
2. Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry.
Ritvo P; Edwards SA; Glendon G; Mirea L; Knight JA; Andrulis IL; Chiarelli AM
BMC Public Health; 2012 Jul; 12():518. PubMed ID: 22788119
[TBL] [Abstract][Full Text] [Related]
3. Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.
Walker MJ; Mirea L; Glendon G; Ritvo P; Andrulis IL; Knight JA; Chiarelli AM
Breast; 2014 Aug; 23(4):482-8. PubMed ID: 24821458
[TBL] [Abstract][Full Text] [Related]
4. Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.
Walker MJ; Mirea L; Cooper K; Nabavi M; Glendon G; Andrulis IL; Knight JA; O'Malley FP; Chiarelli AM
Fam Cancer; 2014 Jun; 13(2):163-72. PubMed ID: 24097051
[TBL] [Abstract][Full Text] [Related]
5. Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry.
Zhang LR; Chiarelli AM; Glendon G; Mirea L; Edwards S; Knight JA; Andrulis IL; Ritvo P
Eur J Cancer Prev; 2011 Jul; 20(4):255-62. PubMed ID: 21467941
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
[TBL] [Abstract][Full Text] [Related]
8. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Evers C; Dikow N; Sohn C; Heil J; Schott S
Breast Cancer Res Treat; 2016 Apr; 156(2):289-99. PubMed ID: 26960712
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
[TBL] [Abstract][Full Text] [Related]
10. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
11. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
Halapy EE; Chiarelli AM; Klar N; Knight J
J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
[TBL] [Abstract][Full Text] [Related]
12. Screening behavior in women at increased familial risk for breast cancer.
Antill YC; Reynolds J; Young MA; Kirk JA; Tucker KM; Bogtstra TL; Wong SS; Dudding TE; Di Iulio JL; Phillips KA
Fam Cancer; 2006; 5(4):359-68. PubMed ID: 16817030
[TBL] [Abstract][Full Text] [Related]
13. Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec.
Dorval M; Noguès C; Berthet P; Chiquette J; Gauthier-Villars M; Lasset C; Picard C; Plante M; ; ; Simard J; Julian-Reynier C
Eur J Hum Genet; 2011 May; 19(5):494-9. PubMed ID: 21248744
[TBL] [Abstract][Full Text] [Related]
14. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
[TBL] [Abstract][Full Text] [Related]
15. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
[TBL] [Abstract][Full Text] [Related]
16. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.
Isaacs C; Peshkin BN; Schwartz M; Demarco TA; Main D; Lerman C
Breast Cancer Res Treat; 2002 Jan; 71(2):103-12. PubMed ID: 11881908
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
[TBL] [Abstract][Full Text] [Related]
18. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Botkin JR; Smith KR; Croyle RT; Baty BJ; Wylie JE; Dutson D; Chan A; Hamann HA; Lerman C; McDonald J; Venne V; Ward JH; Lyon E
Am J Med Genet A; 2003 Apr; 118A(3):201-9. PubMed ID: 12673648
[TBL] [Abstract][Full Text] [Related]
20. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
Gray SW; O'Grady C; Karp L; Smith D; Schwartz JS; Hornik RC; Armstrong K
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1303-11. PubMed ID: 19318436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
